Format

Send to

Choose Destination
Clin Geriatr Med. 2007 May;23(2):371-90, vii.

Polypharmacy and the geriatric patient.

Author information

1
Maryland Poison Center, University of Maryland, School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA.

Abstract

The older adult population is increasing and with it, the risk of polypharmacy. Multiple physicians treating one patient, increasing comorbidities, and an increase in the variety of drugs available contribute to the adverse effects of polypharmacy on the elderly patient. Application of Beers criteria, appropriate therapeutic drug monitoring, and careful, periodic review of the patient's medication list will assist with preventing the sometimes lethal complications of polypharmacy.

PMID:
17462523
DOI:
10.1016/j.cger.2007.01.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center